• The US FDA provides the highest hurdle standard globally for the
approval of new drug and therapy treatments
• Approvals process is a detailed and lengthy process, involving
clinical trials over 3 phases and other FDA mandated requirements
• Onerous processed highlighted by the fact the FDA only approved
a total of 18 drugs last year
• US FDA approval process is a major catalyst for Value for Prima
Prima is in the final stages of its commercialisation timeline and will
commence its Stage III Pivotal Clinical Trial with the US FDA midyear
before seeking FDA approval to licence the product for
commercial use
http://www.primabiomed.com.au/projects/prodDocuments/PRR%20ASX%20Investor%20Presentation%2021April%2009.pdf
- Forums
- ASX - By Stock
- IMM
- worst corporate governance on the asx
worst corporate governance on the asx, page-101
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $436.3M |
Open | High | Low | Value | Volume |
30.5¢ | 31.3¢ | 30.0¢ | $960.6K | 3.161M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 188729 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 46153 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 188729 | 0.300 |
12 | 236310 | 0.295 |
17 | 444259 | 0.290 |
8 | 1046339 | 0.285 |
9 | 253967 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 46153 | 2 |
0.315 | 83754 | 5 |
0.320 | 172037 | 5 |
0.325 | 239547 | 4 |
0.330 | 68045 | 5 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |